Walter Wahli

Q: What Schools Are Affiliated With Walter Wahli

Walter Wahli is affiliated with the following schools: University of Lausanne, Federal University of Toulouse Midi-Pyrénées, Université de Montréal, Imperial College London, Cornell University, University of Bern, University of Geneva, Nanyang Technological University

Walter Wahli's AcademicInfluence.com Rankings

Walter Wahli

Biology

#4525

World Rank

#6740

Historical Rank

Cell Biology

#122

World Rank

#127

Historical Rank

Molecular Biology

#379

World Rank

#386

Historical Rank

Neuroscience

#506

World Rank

#525

Historical Rank

biology Degrees

Download Badge

Biology

Walter Wahli's Degrees

PhD Biochemistry University of Geneva
Masters Biochemistry University of Geneva
Bachelors Biochemistry University of Geneva

Why Is Walter Wahli Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Walter Wahli is a Swiss biologist and a professor at the University of Lausanne and at Nanyang Technological University of Singapore. His research has contributed to the understanding of the control of metabolism by regulation of gene expression. He is known for working on the nuclear receptors, Peroxisome proliferator-activated Receptors, known as PPARs, involved in the energy balance of the body.

(See a Problem?)

Walter Wahli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Peroxisome proliferator-activated receptors: nuclear control of metabolism. (1999) (3106)
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. (1996) (2181)
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ (1997) (1982)
Roles of PPARs in health and disease (2000) (1949)
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting (1999) (1433)
The PPARα–leukotriene B4 pathway to inflammation control (1996) (1321)
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors (1992) (1309)
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. (1997) (1188)
A Unified Nomenclature System for the Nuclear Receptor Superfamily (1999) (1152)
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors (2006) (946)
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. (1993) (936)
Transcriptional regulation of metabolism. (2006) (850)
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. (1999) (801)
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. (1997) (774)
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. (2006) (746)
Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. (1996) (724)
Peroxisome-proliferator-activated receptors and cancers: complex stories (2004) (583)
PPARs at the crossroads of lipid signaling and inflammation (2012) (552)
Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene* (2000) (534)
A high-efficiency HeLa cell nuclear transcription extract. (1988) (509)
Peroxisome proliferator-activated receptors: insight into multiple cellular functions. (2000) (483)
Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription (2002) (472)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ (2005) (463)
Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de Novo Recruitment of Brown Adipocytes (2010) (445)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD (2016) (426)
Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*) (1995) (421)
The PPARalpha-leukotriene B4 pathway to inflammation control. (1996) (418)
The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity* (2006) (414)
Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice (2001) (410)
Differential Expression of Peroxisome Proliferator-Activated Receptor-α, -β, and -γ during Rat Embryonic Development. (1998) (401)
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding. (2001) (401)
Critical roles of PPARβ/δ in keratinocyte response to inflammation (2001) (398)
Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer (2001) (374)
Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. (2004) (372)
Nuclear hormone receptor coregulators in action: diversity for shared tasks. (2000) (370)
Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. (2002) (369)
Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA (1997) (365)
Nutrigenomics and nutrigenetics: the emerging faces of nutrition (2005) (342)
DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements (1997) (338)
A Simplified In Situ Hybridization Protocol Using Non-radioactively Labeled Probes to Detect Abundant and Rare mRNAs on Tissue Sections (1998) (336)
Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm (*) (1996) (334)
Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor alpha defines a novel positive feedback loop in the rodent liver circadian clock. (2006) (314)
PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes (2006) (313)
PPARs: transcriptional effectors of fatty acids and their derivatives (2002) (310)
The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis* (2007) (305)
Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... (1995) (293)
Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) (1993) (288)
Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression (1991) (282)
The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment* (2004) (282)
Vitellogenesis and the vitellogenin gene family. (1981) (281)
Peroxisome proliferator activated receptor agonists. (1997) (256)
Be fit or be sick: peroxisome proliferator-activated receptors are down the road. (2004) (232)
The N‐terminal DNA‐binding ‘zinc finger’ of the oestrogen and glucocorticoid receptors determines target gene specificity. (1988) (232)
Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. (1994) (232)
Involvement of PPAR nuclear receptors in tissue injury and wound repair. (2006) (221)
Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor β/δ (2006) (221)
The G0/G1 switch gene 2 is a novel PPAR target gene. (2005) (220)
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? (1998) (219)
Evolution and expression of vitellogenin genes. (1988) (217)
Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. (1995) (216)
Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats (2011) (216)
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions. (1999) (211)
PixFRET, an ImageJ plug‐in for FRET calculation that can accommodate variations in spectral bleed‐throughs (2005) (206)
In vivo activation of PPAR target genes by RXR homodimers (2004) (206)
The estrogen‐responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid‐responsive element. (1987) (204)
A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. (2002) (204)
Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. (2000) (204)
Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression (2006) (203)
PPARα governs glycerol metabolism (2004) (201)
Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. (1984) (198)
A nucleosome‐dependent static loop potentiates estrogen‐regulated transcription from the Xenopus vitellogenin B1 promoter in vitro. (1993) (196)
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. (2004) (192)
The gut microbiota influences skeletal muscle mass and function in mice (2019) (192)
PPARs in diseases: control mechanisms of inflammation. (2005) (190)
Dosage-Dependent Effects of Akt1/Protein Kinase Bα (PKBα) and Akt3/PKBγ on Thymus, Skin, and Cardiovascular and Nervous System Development in Mice (2005) (189)
Critical roles of PPAR beta/delta in keratinocyte response to inflammation. (2001) (186)
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. (1996) (182)
Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. (2007) (177)
Vitellogenin in Xenopus laevis is encoded in a small family of genes (1979) (175)
The peroxisome proliferator‐activated receptor α regulates amino acid metabolism (2001) (175)
Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. (1998) (175)
PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathways a (1996) (170)
PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. (2006) (169)
Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes (2005) (160)
Peroxisome proliferator-activated receptors: finding the orphan a home (1994) (154)
Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. (2010) (150)
High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine (2016) (149)
Cooperative binding of estrogen receptor to imperfect estrogen‐responsive DNA elements correlates with their synergistic hormone‐dependent enhancer activity. (1989) (147)
Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. (2001) (144)
Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine (2001) (143)
A proline-rich TGF-beta-responsive transcriptional activator interacts with histone H3. (1995) (139)
Direct visualization of supercoiled DNA molecules in solution. (1990) (139)
Peroxisome Proliferator-Activated Receptors Mediate Host Cell Proinflammatory Responses to Pseudomonas aeruginosa Autoinducer (2008) (137)
Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes (2005) (134)
Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. (2005) (133)
Peroxisome Proliferator-activated Receptor Mediates Cross-talk with Thyroid Hormone Receptor by Competition for Retinoid X Receptor (1995) (133)
PPAR expression and function during vertebrate development. (2002) (130)
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. (2003) (130)
Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. (1986) (129)
Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. (1995) (128)
PPARalpha governs glycerol metabolism. (2004) (128)
Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. (2003) (125)
PPARs Mediate Lipid Signaling in Inflammation and Cancer (2008) (123)
Activation of Peroxisome Proliferator–Activated Receptor β/δ Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-κB Activity via Extracellular Signal–Related Kinase 1/2 (2008) (123)
Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet (2011) (123)
PPARs as drug targets to modulate inflammatory responses? (2004) (123)
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models (2017) (122)
Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells* (2002) (122)
Peroxisome Proliferator-activated Receptor β Regulates Acyl-CoA Synthetase 2 in Reaggregated Rat Brain Cell Cultures* (1999) (122)
Fat poetry: a kingdom for PPARγ (2007) (121)
Fluorescence Imaging Reveals the Nuclear Behavior of Peroxisome Proliferator-activated Receptor/Retinoid X Receptor Heterodimers in the Absence and Presence of Ligand*♦ (2005) (120)
Loss of Egg Yolk Genes in Mammals and the Origin of Lactation and Placentation (2008) (119)
Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene. (1987) (118)
Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. (2002) (112)
Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids (1993) (109)
Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. (2005) (108)
Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor (1997) (105)
Regulation of epithelial–mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing (2009) (105)
PPARα Structure-Function Relationships Derived from Species-Specific Differences in Responsiveness to Hypolipidemic Agents (1997) (101)
Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. (2009) (100)
Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. (2005) (99)
PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway (2006) (97)
Erratum: Corrigendum: The European dimension for the mouse genome mutagenesis program (2004) (95)
Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. (2001) (93)
IL‐13 induces expression of CD36 in human monocytes through PPARγ activation (2007) (92)
Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes. (2007) (92)
Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. (1995) (90)
Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts (2011) (89)
Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? (1993) (88)
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. (2006) (88)
Peroxisome Proliferator‐Activated Receptors and Lipid Metabolism a (1993) (87)
Role of the circadian clock gene Per2 in adaptation to cold temperature. (2013) (86)
FTZ-F1-related orphan receptors in Xenopus laevis: transcriptional regulators differentially expressed during early embryogenesis (1994) (84)
A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response (2017) (84)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
A common ancestor DNA motif for invertebrate and vertebrate hormone response elements. (1991) (80)
PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism (2014) (80)
PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. (2011) (80)
Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals (2016) (80)
Comparative analysis of the structural organization of two closely related vitellogenin genes in X. laevis (1980) (79)
The apical localization of transcribing RNA polymerases on supercoiled DNA prevents their rotation around the template. (1992) (79)
Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. (2006) (75)
Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. (2005) (75)
Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. (2009) (75)
Peroxisome Proliferator Activated Receptor Gamma Controls Mature Brown Adipocyte Inducibility through Glycerol Kinase. (2018) (75)
The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells (2012) (74)
Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1. (1999) (74)
Essential role of Smad3 in the inhibition of inflammation‐induced PPARβ/δ expression (2004) (74)
A gut feeling of the PXR, PPAR and NF‐κB connection (2008) (74)
A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. (2006) (73)
Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways (1993) (72)
Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes (2011) (72)
The anti-apoptotic role of PPARβ contributes to efficient skin wound healing (2003) (71)
Steroid and nuclear receptors Villefranche‐sur‐Mer, France, May 25–27, 1999 (1999) (70)
Synergistic transcriptional activation by CTF/NF-I and the estrogen receptor involves stabilized interactions with a limiting target factor (1991) (69)
Kinase signaling cascades that modulate peroxisome proliferator-activated receptors. (2005) (68)
Quantitation of vitellogenin messenger RNA in the liver of male xenopus toads during primary and secondary stimulation by estrogen (1977) (68)
Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors (2007) (68)
The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. (2007) (67)
Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter. (1995) (67)
Fat poetry: a kingdom for PPAR gamma. (2007) (66)
Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor α (PPARα) activity (2011) (66)
Vertebrate and nematode genes coding for yolk proteins are derived from a common ancestor. (1987) (64)
PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. (2003) (62)
PPARbeta/delta regulates paneth cell differentiation via controlling the hedgehog signaling pathway. (2006) (62)
GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation (2012) (62)
Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogenic compounds. (2000) (62)
Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine. (2001) (61)
Impaired expression of NADH dehydrogenase subunit 1 and PPARgamma coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone. (2004) (61)
Complementary DNA cloning of complement C8 beta and its sequence homology to C9. (1987) (61)
Application of recombinant DNA technology to questions of developmental biology: a review. (1979) (61)
Sex differences in nuclear receptor-regulated liver metabolic pathways. (2011) (61)
PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells. (2014) (61)
Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 ioPromoter* (1997) (60)
New insights into the role of PPARs. (2011) (60)
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease (2017) (60)
PPAR: a Key Nuclear Factor in Nutrient / Gene Interactions? (1995) (60)
The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor β/δ Potentiates Cell Chemotactism, Polarization, and Migration (2007) (59)
The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells (2012) (59)
Epithelium-Mesenchyme Interactions Control the Activity of Peroxisome Proliferator-Activated Receptor β/δ during Hair Follicle Development (2005) (59)
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer (2003) (58)
Estrogen-dependent in vitro transcription from the vitellogenin promoter in liver nuclear extracts. (1988) (58)
Comparison of the organization and fine structure of a chicken and a Xenopus laevis vitellogenin gene. (1987) (57)
9‐cis‐Retinoic acid enhances fatty acid‐induced expression of the liver fatty acid‐binding protein gene (1997) (57)
Stage-specific Integration of Maternal and Embryonic Peroxisome Proliferator-activated Receptor δ Signaling Is Critical to Pregnancy Success* (2007) (57)
Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member (2003) (55)
Regional variations in ABC transporter expression along the mouse intestinal tract. (2004) (55)
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ. (2016) (54)
Functions of the Peroxisome Proliferator-Activated Receptor (PPAR) α and β in Skin Homeostasis, Epithelial Repair, and Morphogenesis (2006) (54)
Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. (1999) (53)
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment (2019) (53)
Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis (2004) (52)
Size, complexity and abundance of a specific poly(A)-containing RNA of liver from male Xenopus induced to vitellogenin synthesis by estrogen. (1976) (52)
Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells* (2007) (52)
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome (2017) (51)
Complex organization of CTF/NF-I, C/EBP, and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene. (1994) (51)
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity (2018) (51)
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease (2020) (50)
Peroxisome proliferator-activated receptor-β as a target for wound healing drugs (2004) (50)
Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. (2005) (49)
Lack of Smad3 signaling leads to impaired skeletal muscle regeneration. (2012) (49)
Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia. (2011) (48)
Guiding Ligands to Nuclear Receptors (2007) (48)
A nuclear factor I-like activity and a liver-specific repressor govern estrogen-regulated in vitro transcription from the Xenopus laevis vitellogenin B1 promoter (1989) (47)
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants (2020) (46)
Peroxisome Proliferator-Activated Receptor (PPAR)-β as a Target for Wound Healing Drugs (2004) (45)
PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice. (2012) (44)
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology. (2017) (44)
Peroxisome Proliferator Activated Receptors (2005) (44)
Critical roles of the nuclear receptor PPARβ (peroxisome-proliferator-activated receptor β) in skin wound healing (2004) (43)
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors (cid:97) and (cid:103) (1997) (43)
Isolation of two closely related vitellogenin genes, including their flanking regions, from a Xenopus laevis gene library. (1980) (43)
The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration. (2007) (42)
Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer (2013) (42)
Hepatic PPARα is critical in the metabolic adaptation to sepsis. (2019) (41)
Chemical Probes That Differentially Modulate Peroxisome Proliferator-activated Receptor α and BLTR, Nuclear and Cell Surface Receptors for Leukotriene B4 * (1999) (41)
Peroxisome proliferator-activated receptor agonists. (1997) (41)
Myostatin augments muscle-specific ring finger protein-1 expression through an NF-kB independent mechanism in SMAD3 null muscle. (2014) (41)
Transcriptional Repression of Peroxisome Proliferator-activated Receptor β/δ in Murine Keratinocytes by CCAAT/Enhancer-binding Proteins* (2005) (40)
The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. (2013) (40)
Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance (2007) (40)
Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha. (2004) (40)
Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action. (2004) (39)
Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin. (2000) (38)
A Concerted Kinase Interplay Identifies PPARγ as a Molecular Target of Ghrelin Signaling in Macrophages (2009) (38)
Functional role of RXRs and PPARγ in mature adipocytes (2005) (38)
Insights into the role of hepatocyte PPARα activity in response to fasting (2017) (38)
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases (2005) (38)
Regulation of the DNA-binding and transcriptional activities of Xenopus laevis NFI-X by a novel C-terminal domain (1995) (38)
The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice (2011) (38)
Cloning and characterization of synthetic sequences from the Xenopus iaevis vitellogenin structural gene. (1978) (38)
Genetic- or Transforming Growth Factor-β1-induced Changes in Epidermal Peroxisome Proliferator-activated Receptor β/δ Expression Dictate Wound Repair Kinetics* (2005) (36)
PPARs and Microbiota in Skeletal Muscle Health and Wasting (2020) (36)
Evolution of vitellogenin genes: comparative analysis of the nucleotide sequences downstream of the transcription initiation site of four Xenopus laevis and one chicken gene. (1984) (36)
Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family (1989) (36)
Insights into the Role of PPARβ/δ in NAFLD (2018) (35)
Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. (2005) (34)
Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism (2018) (34)
Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing. (2005) (34)
Microsomal Triglyceride Transfer Protein Promotes the Secretion of Xenopus laevis Vitellogenin A1* (2005) (34)
Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. (2004) (33)
PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium (2017) (33)
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice. (2013) (33)
Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptorα Helix 12 Dynamic Behavior* (2007) (33)
Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism (2016) (33)
Authorship in scientific publications: analysis and recommendations. (2015) (32)
Absence of Intestinal PPARγ Aggravates Acute Infectious Colitis in Mice through a Lipocalin-2–Dependent Pathway (2014) (32)
Expression of human estrogen receptor mutants in Xenopus oocytes: correlation between transcriptional activity and ability to form protein‐DNA complexes. (1988) (32)
PPARs: nuclear receptors for fatty acids, eicosanoids, and xenobiotics. (1999) (32)
The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology (2019) (31)
Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member. (2003) (30)
Estrogen receptor level determines sex-specific in vitro transcription from the Xenopus vitellogenin promoter. (1990) (29)
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency (2016) (29)
Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis. (2006) (29)
Sequence homologies within the 5′ end region of the estrogen‐controlled vitellogenin gene in Xenopus and chicken. (1983) (28)
Contents Vol. 54, 2000 (2001) (28)
Erratum: Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription (Molecular and Cellular Biology (2002) 22:14 (5114-5127)) (2002) (28)
Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. (2004) (28)
Vitellogenin genes A1 and B1 are linked in the Xenopus laevis genome. (1982) (27)
Isolation and translation in vitro of four related vitellogenin mRNAs of estrogen-stimulated Xenopus laevis. (1980) (27)
Studying Wound Repair in the Mouse (2013) (27)
Complementary intestinal mucosa and microbiota responses to caloric restriction (2018) (27)
cis- and trans-acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis. (1989) (26)
Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway (2018) (26)
Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? (2003) (25)
Functional role of RXRs and PPARgamma in mature adipocytes. (2005) (24)
Transcriptional potentiation of the vitellogenin B1 promoter by a combination of both nucleosome assembly and transcription factors: an in vitro dissection (1990) (24)
Two functional forms of the Xenopus laevis estrogen receptor translated from a single mRNA species. (1994) (24)
PPAR gamma: ally and foe in bone metabolism. (2008) (23)
The human estrogen receptor can regulate exogenous but not endogenous vitellogenin gene promoters in a Xenopus cell line. (1988) (23)
Peroxisome Proliferator-activated Receptor β/δ Induces Myogenesis by Modulating Myostatin Activity* (2012) (23)
Vitellogenin B2 gene in Xenopus laevis: isolation, in vitro transcription and relation to other vitellogenin genes. (1983) (22)
Promoter Rearrangements Cause Species-specific Hepatic Regulation of the Glyoxylate Reductase/Hydroxypyruvate Reductase Gene by the Peroxisome Proliferator-activated Receptor α* (2005) (22)
Xenopus vitellogenin genes. (1985) (21)
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors (2018) (21)
PPAR-β/δ activation promotes phospholipid transfer protein expression. (2015) (21)
Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes. (2020) (21)
PPAR modulation of kinase-linked receptor signaling in physiology and disease. (2010) (20)
Role of Dietary Supplements and Probiotics in Modulating Microbiota and Bone Health: The Gut-Bone Axis (2022) (20)
Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. (2005) (20)
Decreased expression of peroxisome proliferator‐activated receptor α and liver fatty acid binding protein after partial hepatectomy of rats and mice (2005) (20)
Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity (2020) (19)
Linkage arrangement in the vitellogenin gene family of Xenopus laevis as revealed by gene segregation analysis. (1986) (19)
PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation. (2015) (19)
Ribosomal protein L27 is identical in chick and rat. (1991) (19)
Fate of linear and supercoiled multinucleosomic templates during transcription. (1995) (19)
Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases. (2005) (18)
Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression (2018) (18)
The Vi element. A transposon-like repeated DNA sequence interspersed in the vitellogenin locus of Xenopus laevis. (1985) (18)
Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction (2016) (18)
Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element. (1995) (18)
The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet (2014) (17)
Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer (2015) (17)
Electron microscopic visualization of protein‐DNA interactions at the estrogen responsive element and in the first intron of the Xenopus laevis vitellogenin gene. (1987) (17)
PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice (2015) (17)
PCR driven DNA-DNA competitive hybridization: a new method for sensitive differential cloning. (1991) (17)
Transcriptional Regulation by Triiodothyronine of the UDP-glucuronosyltransferase Family 1 Gene Complex in Rat Liver (1997) (17)
Transcription of single-copy vitellogenin gene of Xenopus involves expression of middle repetitive DNA (1981) (17)
The Role of PPARβ/δ in Melanoma Metastasis (2018) (16)
PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal–Epithelial Crosstalk and Carcinogenesis (2021) (16)
Nuclear Hormone Receptors and Mouse Skin Homeostasis: Implication of PPARβ (2001) (15)
A trilogy of glucocorticoid receptor actions (2016) (15)
GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK. (2020) (14)
Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis. (2015) (14)
Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis. (2019) (14)
Visualization of RNA polymerase II ternary transcription complexes formed in vitro on a Xenopus laevis vitellogenin gene. (1985) (14)
Integrating nuclear receptor mobility in models of gene regulation (2006) (13)
Electron-microscopic demonstration of terminal and internal initiation sites for cDNA synthesis on vitellogenin mRNA. (1978) (13)
Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue (2021) (13)
The emerging role of Nrf2 in dermatotoxicology (2014) (12)
Regulation of the vitellogenin gene B1 promoter after transfer into hepatocytes in primary cultures (1998) (12)
Fatty acid synthesis and PPARalpha hand in hand. (2009) (12)
Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target (2021) (12)
A liver protein fraction regulating hormone-dependent in vitro transcription from the vitellogenin genes induces their expression in Xenopus oocytes. (1991) (12)
Injection of partially purified estrogen receptor protein from Xenopus liver nuclei into oocytes activates the silent vitellogenin locus. (1984) (12)
Looking at nuclear receptors from the heights of Erice (2002) (11)
Immuno-electron microscopic identification of human estrogen receptor-DNA complexes at the estrogen-responsive element and in the first intron of a Xenopus vitellogenin gene. (1988) (11)
Peroxisome Proliferator-Activated Receptor-- Null Mice Have Increased White Adipose Tissue Glucose Utilization , GLUT 4 , and Fat Mass : Role in Liver and Brain (2006) (11)
ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response (2018) (11)
Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm (2020) (10)
Inhibition of Estrogen-Responsive Gene Activation by the Retinoid X Receptor β: Evidence for Multiple Inhibitory Pathways (1993) (10)
Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis (2019) (10)
Structure and Function of the Estrogen Receptor (1999) (10)
PPARβ Interprets a Chromatin Signature of Pluripotency to Promote Embryonic Differentiation at Gastrulation (2013) (10)
Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity. (2016) (10)
An immuno-electron microscopical analysis of transcribing multinucleosomal templates: what happens to the histones? (2000) (9)
Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease (2013) (9)
The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice. (2018) (9)
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance (2021) (9)
Scattering of repetitive DNA sequences in the albumin and vitellogenin gene loci of Xenopus laevis. (1983) (9)
The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice (2021) (9)
The distribution of the dinucleotide CpG and cytosine methylation in the vitellogenin gene family (2005) (9)
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation Published, JLR Papers in Press, November 16, 2002. DOI 10.1194/jlr.M200376-JLR200 (2003) (8)
PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle (2020) (8)
The Interleukin 1 receptor antagonist is a direct target gene of PPAR  in (2011) (7)
Evidence against close linkage of the loci for fraXq of Martin-Bell syndrome and for factor IX (2004) (7)
Depletion of Gram-Positive Bacteria Impacts Hepatic Biological Functions During the Light Phase (2019) (7)
Hepatic Fasting-Induced PPARα Activity Does Not Depend on Essential Fatty Acids (2016) (7)
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity (2021) (7)
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity. (2022) (7)
LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling (2021) (7)
Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells through a Heavy Isotope Pulse/Trace Proteomic Approach (2020) (6)
Nutrigenomic foods (2013) (6)
Identification of two steroid-responsive promoters of different strength controlled by the same estrogen-responsive element in the 5'-end region of the Xenopus laevis vitellogenin gene A1. (1989) (6)
Physiological ligands of PPARs in inflammation and lipid homeostasis (2006) (6)
Gene transfer into Xenopus hepatocytes: transcriptional regulation by members of the nuclear receptor superfamily (1994) (6)
GW501516-activated PPARbeta/delta promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation (2019) (6)
Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice (2020) (5)
Beneficial effects of combinatorial micronutrition on body fat and atherosclerosis in mice (2011) (5)
PPARs in fetal and early postnatal development (2006) (5)
PPAR Disruption : Cellular Mechanisms and Physiological Consequences (2008) (5)
PPAR-beta/delta activation promotes phospholipid transfer protein expression (2015) (5)
Functional interaction between the estrogen receptor and CTF1: analysis of the vitellogenin gene B1 promoter in yeast. (1998) (5)
Investigating the Role of PPARβ/δ in Retinal Vascular Remodeling Using Pparβ/δ-Deficient Mice (2020) (4)
Erratum: Inhibition of estrogen-responsive gene activation by the retinoid X receptor β: Evidence for multiple inhibitory pathways (Molecular and Cellular Biology 13:4 (2258)) (1993) (4)
Peroxisome proliferator-activated receptor β/δ: a master regulator of metabolic pathways in skeletal muscle (2010) (4)
Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes. (2019) (4)
Understanding the coordinated effects of PPARs on lipid metabolism using microarrays (2005) (4)
Chemical probes that differentially modulate PPARα and BLTR, nuclear and cell surface receptors for leukotriene B4 (1999) (4)
The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expression. (2022) (4)
Lack of Smad 3 signaling leads to impaired skeletal muscle regeneration (2012) (4)
A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor -Dependent Pathway (2006) (3)
PPARα, A Key Regulator of Hepatic Energy Homeostasis in Health and Disease (2010) (3)
The Potential of the FSP1cre-Pparb/d−/− Mouse Model for Studying Juvenile NAFLD (2019) (3)
PPARα: Tempting Fate with Fat (1998) (3)
Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus (2022) (3)
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor (2022) (3)
GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation (2012) (3)
Invalidation of the Transcriptional Modulator of Lipid Metabolism PPARβ/δ in T Cells Prevents Age-Related Alteration of Body Composition and Loss of Endurance Capacity (2021) (3)
PPAR b / d affects pancreatic b cell mass and insulin secretion in mice (2018) (3)
Roles of Estrogens in the Healthy and Diseased Oviparous Vertebrate Liver (2021) (3)
YOLK PROTEIN EVOLUTION - COMPARISON OF AMPHIBIAN, AVIAN, INSECT AND NEMATODE VITELLOGENINS (1986) (3)
Factors promoting the establishment of primary cultures of liver cells fromXenopus larvae (1977) (2)
Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes (2019) (2)
Functional role ofRXRs and PPAR g in mature adipocytes (2005) (2)
Intestinal antiinﬂammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor- (cid:1) (2005) (2)
Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats Published, JLR Papers in Press, October 16, 2003. DOI 10.1194/jlr.M300208-JLR200 (2004) (2)
Nuclear Hormone Receptors and Epidermal Differentiation (2015) (2)
Sensors for metabolic control : a regulatory network of nuclear receptors (2002) (2)
Erratum: Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals (2016) (2)
Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease (2022) (2)
Roles of the peroxisome proliferator-activated receptor (PPAR) α and β/δ in skin wound healing (2007) (2)
PPARs: Nuclear Hormone Receptors Involved in the Control of Inflammation (2004) (1)
Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription (2002) (1)
Kinase signaling cascades that modulate peroxisome proliferator-activated receptors: [Curr. Opin. Cell Biol. 17 (2005) 216] (2005) (1)
2WS08-2 PPARs control cell physiology and survival (2003) (1)
The emerging role of Nrf 2i n dermatotoxicology (2014) (1)
Transposition of a bacterial IS3 element into a Xenopus Vi-element. (1986) (1)
Liver PPARα is protective against NAFLD (2018) (1)
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations (2021) (1)
A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects. (2022) (1)
Retention of the differentiated state by larvalXenopus liver cells in primary culture (1978) (1)
Steroid hormone and related receptors. (1997) (1)
Title : The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt 5 a signalling in vascular smooth muscle cells (1)
Metabolism and Metabolomics of Liver in Health and Disease (2021) (1)
Subject Index Vol. 54, 2000 (2001) (1)
Leukotriene B4: agonist for the fat regulator PPARα (1998) (1)
PPARs: Lipid Sensors that Regulate Cell Differentiation Processes (2006) (1)
The hepatocyte insulin receptor is required to program rhythmic gene expression and the liver clock (2021) (1)
Activation of PPAR delta Regulates Ywhae (Encoding 14-3-3 epsilon Protein), a Gene Required for Ventricular Morphogenesis (2009) (1)
PPARsMediate Lipid Signaling in Inflammation and Cancer (2014) (1)
PPARs : nuclear hormone receptors controlling peroxisomal fatty acid β-oxidation (1995) (1)
A function for PPAR-β in rat stellate cell activation (2000) (0)
PPARs: Three isotypes for multiple functions (2001) (0)
Induction of acyl-coenzyme A synthetase (ACS) gene expression by fibrates is mediated by a PPAR-responsive element in the 1C promoter of the ACS gene (1994) (0)
Effect PPARb/d knockout in white adipose tissue (2007) (0)
Peroxisome Proliferator Activated Receptor Alpha Coordinates Intermediary Metabolism During Fasting (2002) (0)
A common ancestorDNA motif forinvertebrate and vertebrate hormone responseelements (1991) (0)
transcription fromtheXenopus vitellogenin Bipromoterinvitro (1993) (0)
Nucleic Acids Research Scattering of repetitive DNA sequences in the albumin and vtteflogenln gene Iod of Xenopus laevis (2005) (0)
Sequence homologies within the5' endregion oftheestrogen- controlled vitellogenin geneinXenopus andchicken (1983) (0)
PPARs: nuclear receptors involved in the control of inflammation (2003) (0)
The Loss of PPARα in Adipocytes Induces Lipogenesis via the PASK‐SREBP1 Signaling Axis (2022) (0)
the mouse intestinal tract Regional variations in ABC transporter expression along (2013) (0)
Author Correction: EMPReSS: standardized phenotype screens for functional annotation of the mouse genome (2022) (0)
675. Exploring the Effects of Stroma-Derived PPARB Signaling in Colorectal Tumorigenesis (2016) (0)
Disease prevention through nutrition (2013) (0)
PPARs : lipid sensors that affect differentiation processes (2004) (0)
PPARs as Key Mediators in the Regulation of Metabolism and Inflammation (2022) (0)
Inhibition ofEstrogen-Responsive GeneActivation bythe Retinoid X Receptor ,B: Evidence forMultiple Inhibitory Pathways (1993) (0)
The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice (2021) (0)
Tissue Repair and Cancer Control through PPARs and Their Coregulators (2008) (0)
PPARβ/δamelioratesfructose-inducedinsulinresistanceinadipocytesby preventing Nrf2 activation (2015) (0)
Angiopoietin-like 4 shapes the intrahepatic T-cell landscape via eIF2α signaling during steatohepatitis in diet-induced NAFLD (2023) (0)
Complementary intestinal mucosa and microbiota responses to caloric restriction (2018) (0)
Transcriptional Potentiation oftheVitellogenin BiPromoter bya Combination ofBothNucleosome Assembly andTranscription Factors: an InVitro Dissection (1990) (0)
Cell Metabolism Previews PPAR g : Ally and Foe in Bone Metabolism (0)
"Every day I dream ..." An interview with the Rwandan Health Minister. (2016) (0)
Parts of the bothrops moojeni snake venom activated lipid synthesis and PPARA, B, Gamma 2 in transiently transfected sz95 sebocytes (2009) (0)
Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice (2020) (0)
PPARs in health and disease : central roles in energy homeostasis and tissue repair. (2004) (0)
PPARα in hepatocytes integrates microbiome-derived signals and is protective against fatty liver in both neonate and adult mice (2017) (0)
Vitellogenin genes Al and BI are linked in the Xenopus laevis genome ( gene libraries / in-vitro transcription / gene and genome duplication ) (0)
The Developing Mouse Whiskerpad: Pattern Formation at the Periphery of a Highly Organized Somatosensory Pathway (1992) (0)
Induction of acyl-coenzyme a synthetase expression by fibrates and fatty acids is mediated through activation of the peroxisome proliferator activated receptor (1995) (0)
Title The peroxisomal enzyme L-PBE is required to preventthe dietary toxicity of medium-chain Fatty acids (2017) (0)
Title PPAR Is Required for PPAR Action in Regulation of BodyWeight and Hepatic Steatosis in Mice (2019) (0)
ReviewArticle PPARs Mediate Lipid Signaling in Inflammation and Cancer (2008) (0)
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and g ( nuclear receptor y ligand y transcription y fibrate ) (1997) (0)
Isolation of two closely related vitel flanking regions, from a Xenopus la (recombinant DNA/restriction endonuclease mapping/gene famil (2016) (0)
The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor (cid:2) / (cid:3) Potentiates Cell Chemotactism, Polarization, and Migration (cid:1) † (2007) (0)
Electron Microscope Visualisation of Protein-DNA Complexes (1991) (0)
PPARs and colon cancers : A curse or a cure ? (2006) (0)
Title Selective deletion of PPAR / in fibroblasts causes dermalfibrosis by attenuated LRG 1 expression (2019) (0)
Author response: Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism (2016) (0)
Attenuation of colon infiammation through the RXR/PPARγ heterodimer: A basis for new therapeutic strategies (2001) (0)
PPARβ/δ is not required by PGC‐1α to enhance skeletal muscle oxidative metabolism (1164.3) (2014) (0)
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment (2019) (0)
Table of Contents (1991) (0)
Sensors for Metabolic Control (2002) (0)
V'itellogenin B2 gene in Xenopus laevis: isolation, in vitro trnnscrption and relation to other viteflogenin genes (0)
Pregnane X receptor drives sex-specific liver alterations related to the gut microbiota (2021) (0)
in Physiology and Disease PPAR Modulation of Kinase-Linked Receptor Signaling (2015) (0)
Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression (2018) (0)
PPARα and liver circadian clock Reciprocal regulation of BMAL1 and PPARα defines a novel positive feedback loop in the rodent liver circadian clock (2007) (0)
Heterogeneity in rat hepatic PPAR-α (2000) (0)
PPAR-beta and retinol metabolism related gene-expression in HSC (2002) (0)
Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor (2021) (0)
Investigating the role of PPARβ/δ in retinal angiogenesis (2020) (0)

This paper list is powered by the following services:

Other Resources About Walter Wahli

en.wikipedia.org

What Schools Are Affiliated With Walter Wahli?

Walter Wahli is affiliated with the following schools:

Walter Wahli's Academic­Influence.com Rankings

Walter Wahli's Degrees

Why Is Walter Wahli Influential?

Walter Wahli's Published Works

Published Works

Other Resources About Walter Wahli

What Schools Are Affiliated With Walter Wahli?

Walter Wahli's AcademicInfluence.com Rankings